| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
134,746,000 |
| Market
Cap: |
1.63(B) |
| Last
Volume: |
3,983,089 |
Avg
Vol: |
3,972,216 |
| 52
Week Range: |
$10.73 - $14.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 457 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
3,615 |
34,641 |
2,227,529 |
7,927,750 |
| Total Sell Value |
$43,127 |
$457,999 |
$31,224,010 |
$106,100,189 |
| Total People Sold |
1 |
4 |
5 |
6 |
| Total Sell Transactions |
1 |
4 |
17 |
31 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burgess Justin |
Chief Accounting Officer |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
11,635 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,833 |
212,312 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,333 |
7,692 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2024-02-05 |
4 |
D |
$10.36 |
$41,885 |
D/D |
(4,043) |
55,882 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2024-02-05 |
4 |
D |
$12.79 |
$85,540 |
D/D |
(6,688) |
15,201 |
|
- |
|
| Burgess Justin |
Chief Accounting Officer |
• – – |
2024-02-05 |
4 |
D |
$12.79 |
$44,100 |
D/D |
(3,448) |
4,968 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2024-02-05 |
4 |
D |
$12.79 |
$219,080 |
D/D |
(17,129) |
191,479 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2024-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,750 |
208,608 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
59,925 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
21,889 |
|
- |
|
| Burgess Justin |
Chief Accounting Officer |
• – – |
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,416 |
8,416 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2024-01-04 |
4 |
AS |
$15.00 |
$22,500 |
D/D |
(1,500) |
49,925 |
|
-26% |
|
| Janssen Robert |
SVP and CMO |
• – – |
2024-01-04 |
4 |
OE |
$9.41 |
$14,115 |
D/D |
1,500 |
51,425 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2024-01-02 |
4 |
AS |
$14.45 |
$130,050 |
D/D |
(9,000) |
3,187 |
|
-23% |
|
| Novack David F |
President & COO |
• – – |
2024-01-02 |
4 |
OE |
$5.42 |
$48,780 |
D/D |
9,000 |
12,187 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2023-12-01 |
4 |
AS |
$13.56 |
$271,200 |
D/D |
(20,000) |
3,187 |
|
-14% |
|
| Novack David F |
President & COO |
• – – |
2023-12-01 |
4 |
OE |
$5.42 |
$108,400 |
D/D |
20,000 |
23,187 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2023-11-03 |
4 |
AS |
$15.00 |
$300,000 |
D/D |
(20,000) |
3,187 |
|
-15% |
|
| Novack David F |
President & COO |
• – – |
2023-11-03 |
4 |
OE |
$5.42 |
$108,400 |
D/D |
20,000 |
23,187 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2023-10-10 |
4 |
AS |
$15.01 |
$26,343 |
D/D |
(1,755) |
49,925 |
|
-16% |
|
| Janssen Robert |
SVP and CMO |
• – – |
2023-10-10 |
4 |
OE |
$9.41 |
$16,515 |
D/D |
1,755 |
51,680 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2023-10-02 |
4 |
AS |
$14.75 |
$595,000 |
D/D |
(40,000) |
3,187 |
|
-14% |
|
| Novack David F |
President & COO |
• – – |
2023-10-02 |
4 |
OE |
$5.42 |
$216,800 |
D/D |
40,000 |
43,187 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2023-10-02 |
4 |
AS |
$15.03 |
$75,375 |
D/D |
(5,015) |
49,925 |
|
-14% |
|
| Janssen Robert |
SVP and CMO |
• – – |
2023-10-02 |
4 |
OE |
$9.41 |
$47,191 |
D/D |
5,015 |
54,940 |
|
- |
|
434 Records found
|
|
Page 2 of 18 |
|
|
0.02 (0.17%) 
